logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
M

Myung‐Ju Ahn

sungkyunkwan university (skku)

24H-index
114Paper Count
2.2KCitation Count
Published Papers 39
Publication Date
logo
Real-world treatment patterns and subsequent treatment effectiveness following frontline brigatinib in the ALTA-1L trial
errFUTURE ONCOLOGY
IF2.6
err2025-12-01
err0
PREAI
errAhn, Myung-Ju; Delmonte, Angelo; Ghosh, Sharmistha; Hochmair, Maximilian; Yang, Tsung-Ying; Yang, James Chih-Hsin; Han, Ji-Youn; Hansen, Karin Holmskov; Wu, Yanyu; Wan, Yin; Lin, Huamao Mark; Kretz, Julian; Hupf, Bradley; Kurec, Ahmet Melih; Churchill, Eric N.; Fram, Robert J.; Cabasag, Citadel Jungco; Goriya, Vishal; Zhao, Yuzhe; Campelo, Maria Rosario Garcia
errShare
errSave
Crizotinib-Associated Uveitis and Scleritis with Abscess Formation
errOCULAR IMMUNOLOGY AND INFLAMMATION
IF2
err2025-11-01
err1
PREAI
errYoon, Je Moon; Nam, Seung Wan; Kim, Min Ji; Ahn, Myung-Ju; Ham, Don-Il
errShare
errSave
Osimertinib before and after chemoradiotherapy for unresectable stage III EGFR-mutated NSCLC: NEOLA Trial Protocol
errFUTURE ONCOLOGY
IF2.6
err2025-11-01
err0
PREAI
errAredo, Jacqueline V.; Peled, Nir; Arriola, Edurne; Wakelee, Heather; Ahn, Myung-Ju; Kwint, Margriet H.; Taylor, Rosemary; van der Gronde, Toon; Nasirova, Feruza; Chen, Ming
errShare
errSave
Phase II study of lazertinib and pemetrexed in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer and leptomeningeal metastases: The KCSG LU 21-01, LAZARUS study
errLung Cancer
IF4.4
err2025-11-01
err0
PREAI
errHyun-Ae Jung; Tae Min Kim; Hye Ryun Kim; Chang Gon Kim; Hee Kyung Ahn; Youngjoo Lee; Yu Jung Kim; Miso Kim; Jeonghwan Youk; Jong-Mu Sun; Se-Hoon Lee; Jin Seok Ahn; Dong-Wan Kim; Myung-Ju Ahn; Bhumsuk Keam
errShare
errSave
A comparison of clinical guidelines; treatment characteristics and outcomes in small cell lung cancer between East Asia and Europe/North America
errFrontiers in Oncology
IF3.3
err2025-10-27
err0
errOAAI
errChi-Lu Chiang; Ross Andrew Soo; Tony Mok; Pei Jye Voon; Lucksamon Thamlikitkul; Ying Cheng; Hidehito Horinouchi; Byong Chul Cho; Krista Lin Xu; Myung-Ju Ahn†
errShare
errSave
Efficacy and safety of brigatinib after alectinib in patients with ALK-positive NSCLC: Integrated analysis of the ALTA-2 and J-ALTA studies
errLung Cancer
IF4.4
err2025-10-09
err0
PREAI
errTony Mok; Makoto Nishio; Tatsuya Yoshida; Myung-Ju Ahn; Kentarou Kudou; Takayuki Asato; Hui Yang; Xin Tong; Sylvie Vincent; Pingkuan Zhang; Nobuyuki Yamamoto; Edward S. Kim
errShare
errSave
Mutation testing, treatment patterns, and outcomes in patients with unresectable stage III EGFR-mutated non-small cell lung cancer treated with chemoradiotherapy: Final analysis of a global real–world study
errLung Cancer
IF4.4
err2025-09-08
err0
PREAI
errMyung-Ju Ahn; Steven H. Lin; Cheng-Ta Yang; Jii Bum Lee; Joel W. Neal; Kyoichi Okishio; Kazumi Nishino; Daniel Smith; Markus Rauter; Maria Jimenez; Feruza Nasirova; YongJin Kim
errShare
errSave
Asian Subgroup Analysis of Patients in the Phase 2 DeLLphi-301 Study of Tarlatamab for Previously Treated Small Cell Lung Cancer
errOncology and Therapy
IF3.2
err2025-09-04
err0
errOAAI
errMyung-Ju Ahn; Byoung Chul Cho; Kadoaki Ohashi; Hiroki Izumi; Jong-Seok Lee; Ji-Youn Han; Chi-Lu Chiang; Shuang Huang; Ali Hamidi; Sujoy Mukherjee; Krista Lin Xu; Hiraoki Akamatsu
errShare
errSave
Final analysis results and patient-reported outcomes from DESTINY-Lung02—a dose-blinded, randomized, phase 2 study of trastuzumab deruxtecan in patients with HER2-mutant metastatic non–small cell lung cancer
errJournal of Thoracic Oncology
IF20.8
err2025-07-30
err0
PREAI
errPasi A. Jänne; Yasushi Goto; Toshio Kubo; Kiichiro Ninomiya; Sang-We Kim; David Planchard; Myung-Ju Ahn; Egbert Smit; Adrianus Johannes de Langen; Maurice Pérol; Elvire Pons-Tostivint; Silvia Novello; Hidetoshi Hayashi; Junichi Shimizu; Dong-Wan Kim; Kaline Pereira; Fu-Chih Cheng; Ayumi Taguchi; Yingkai Cheng; Kyle Dunton; Ahmed Ali; Koichi Goto
errShare
errSave
Activity of Brigatinib in Patients With Crizotinib-Resistant ALK-positive Non–Small-Cell Lung Cancer According to ALK Fusion and Mutation Status
errClinical Lung Cancer
IF3.3
err2025-06-06
err0
errOAAI
errLyudmila Bazhenova; J.G. Hodgson; D. Ross Camidge; Corey J. Langer; Rudolf M. Huber; Dong-Wan Kim; Karen L. Reckamp; Myung-Ju Ahn; Daniel S.W. Tan; Jyoti D. Patel; Sylvie Vincent; Cong Li; Michael J. Humphries; Pingkuan Zhang; Victor M. Rivera; Scott Gettinger
errShare
errSave
Updated Efficacy and Safety From the Phase 2 PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic NSCLC—A Brief Report
errJournal of Thoracic Oncology
IF20.8
err2025-06-04
err0
errOAAI
errGregory J. Riely; Myung-Ju Ahn; Jeffrey M. Clarke; Ibiayi Dagogo-Jack; Raymond Esper; Enriqueta Felip; Francesco Gelsomino; Jonathan W. Goldman; Maen Hussein; Melissa Johnson; Kristen A. Marrone; Daniel Morgensztern; Ernest Nadal; Marcelo V. Negrao; Michael Offin; Mariano Provencio; Suresh S. Ramalingam; Logan Roof; Rachel E. Sanborn; Egbert F. Smit; Anne Tsao; Tiziana Usari; Ann Alcasid; Keith Wilner; Svitlana Tonkovyd; Xiaosong Zhang; Bruce E. Johnson
errShare
errSave
EGFR mutation testing across the osimertinib clinical program
errLUNG CANCER
IF4.4
err2025-06-01
err0
PREAI
errMurat-Onana, Marie Laure; Ramalingam, Suresh S.; Janne, Pasi A.; Gray, Jhanelle E.; Ahn, Myung-Ju; John, Tom; Yatabe, Yasushi; Huang, Xiangning; Rukazenkov, Yuri; Javey, Manana; Brown, Helen; Li-Sucholeiki, Xiaocheng
errShare
errSave
Lazertinib for Patients with NSCLC Harboring Uncommon EGFR Mutations: A Phase II Multicenter Trial
errJournal of Thoracic Oncology
IF20.8
err2025-05-09
err0
errOAAI
errSehhoon Park; Hee Kyung Ahn; Seoyoung Lee; Young Joo Min; Jinyong Kim; Hyun Ae Jung; Jong-Mu Sun; Se-Hoon Lee; Jin Seok Ahn; Myung-Ju Ahn; Jii Bum Lee; Sun Min Lim; Hye Ryun Kim; Byoung Chul Cho; Min Hee Hong
errShare
errSave
The patterns of systemic metastasis in major salivary gland cancer and therapeutic implications
errORAL ONCOLOGY
IF3.9
err2025-05-01
err0
PREAI
errOh, Subi; Kim, Younghac; Kim, Hyojun; Kim, Eunhye; Woo, Sook-young; Choi, Nayeon; Cho, Junhun; Oh, Dongryul; Ahn, Yong-Chan; Park, Sehhoon; Ahn, Myung-Ju; Jeong, Han-Sin
errShare
errSave
Efficacy and safety of brigatinib in patients with ALK TKI-naive advanced ALK plus NSCLC: Integrated analysis of the ALTA-1L and J-ALTA trials
errLUNG CANCER
IF4.4
err2025-03-01
err0
PREAI
errCamidge, D. Ross; Sugawara, Shunichi; Kondo, Masashi; Kim, Hye Ryun; Ahn, Myung-Ju; Yang, James C. H.; Hochmair, Maximilian J.; Lee, Ki Hyeong; Delmonte, Angelo; Kudou, Kentarou; Asato, Takayuki; Hupf, Bradley; Vranceanu, Florin; Fram, Robert J.; Ohe, Yuichiro; Popat, Sanjay
errShare
errSave
The Risk and Reversibility of Osimertinib-Related Cardiotoxicity in a Real-World Population
errJOURNAL OF THORACIC ONCOLOGY
IF20.8
err2025-02-01
err2
PREAI
errBak, Minjung; Park, Hyukjin; Lee, Se-Hoon; Lee, Nuri; Ahn, Myung-Ju; Ahn, Jin Seok; Jung, Hyun Ae; Park, Sehhoon; Cho, Jinhyun; Kim, Jihoon; Park, Sung-Ji; Chang, Sung-A; Lee, Sang-Chol; Park, Seung Woo
errShare
errSave
A Multi-Country Study of the Clinical Course of Extensive-Stage Small Cell Lung Cancer: A Six-Study Analysis of Real-World Treatment Patterns and Outcomes
errCLINICAL EPIDEMIOLOGY
IF3.2
err2025-01-01
err0
errOAAI
errPundole, Xerxes; Younan, Diana; Critchlow, Cathy W.; Puntis, Stephen R.; Soohoo, Melissa; Anderson, Erik S.; Najdi, Rani; Horinouchi, Hidehito; Calvo, Virginia; Cobo, Manuel; Lopez-Castro, Rafael; Bernabe, Reyes; Cho, Juhee; Desai, Parth A.; Ahn, Myung-Ju; Provencio, Mariano
errShare
errSave
Osimertinib long-term tolerability in patients with EGFRm NSCLC enrolled in the AURA program or FLAURA study
errJOURNAL OF POWER SOURCES
IF7.9
err2025-01-01
err0
PREAI
errGarassino, Marina Chiara; He, Yong; Ahn, Myung-Ju; V. Orlov, Sergey; Potter, Vanessa; Kato, Terufumi; Laskin, Janessa; Voon, Pei Jye; Reungwetwattana, Thanyanan; Ramalingam, Suresh S.; Wu, Yi-Long; Albayaty, Muna; Cross, Sarah L.; Huang, Xiangning; Kulkarni, Dakshayini
errShare
errSave
Association between Tumor Size at the Time of Disease Progression and Survival Outcomes
errCANCER RESEARCH AND TREATMENT
IF3.8
err2024-10-22
err0
errOAAI
errMaeng, Chi Hoon; Kim, Bum Jun; Ahn, Myung-Ju; Choi, In Sil; Zang, Dae Young; Kim, Bo-Hyung; Kwon, Minji; Heo, Dae Seog; Keam, Bhumsuk
errShare
errSave
Drug development and evidence for lung cancer targeted therapy in Eastern Asia
errLANCET REGIONAL HEALTH-WESTERN PACIFIC
IF8.1
err2024-08-01
err1
errOAAI
errLiu, Si-Yang Maggie; Jin, Zhen-Yi; Deng, Jia-Yi; Zhong, Si-Min; Ahn, Myung-Ju; Horinouchi, Hidehito; Li, Yangqiu; Wu, Yi-Long
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
P
Pasi A. Jänne
H-index: 163 · Papers: 2.3K
J
James Chih‐Hsin Yang
H-index: 141 · Papers: 1.2K
Y
Yi‐Long Wu
H-index: 135 · Papers: 2.2K
T
Tony Mok
H-index: 131 · Papers: 1.1K
E
Enriqueta Felip
H-index: 129 · Papers: 1.5K
View more